Xeme Biopharma Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Crowdfunding
  • (Cancelled)

  • Latest Deal Amount
  • $225K

Xeme Biopharma General Information

Description

Developer of therapeutic cancer vaccines designed to treat cancer. The company's vaccine activates the undamaged immune system of a patient to be used for more aggressive therapies like chemotherapy, thereby enabling healthcare providers to treat cancer cases that are beyond the current approaches of surgery, radiation, chemotherapy, and passive immunotherapy.

Contact Information

Website
www.xemebiopharma.com
Formerly Known As
Acqusalut Inc.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 7 Deerpark Drive
  • Suite M-1
  • Monmouth Junction, NJ 08852
  • United States
+1 (732)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
R2T Biopharma
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 7 Deerpark Drive
  • Suite M-1
  • Monmouth Junction, NJ 08852
  • United States
+1 (732)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xeme Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Equity Crowdfunding 01-Apr-2021 $225K Cancelled Generating Revenue
7. Merger/Acquisition 17-Mar-2020 Completed Generating Revenue
6. Product Crowdfunding 05-Aug-2018 Completed Generating Revenue
5. Later Stage VC 15-Aug-2017 Completed Generating Revenue
4. Merger/Acquisition 01-Dec-2011 Completed Generating Revenue
3. Angel (individual) 01-Sep-2011 Completed Generating Revenue
2. Grant 01-Jan-2008 $167K Completed Startup
1. Capitalization Completed Startup
To view Xeme Biopharma’s complete valuation and funding history, request access »

Xeme Biopharma Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Xeme Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170224797-A1 Cancer therapy using a vaccine in combination with a cell-based immunotherapeutic agent Inactive 10-Feb-2016
US-20200054726-A1 Cancer therapy using a vaccine in combination with a cell-based immunotherapeutic agent Inactive 10-Feb-2016
US-11766473-B2 Therapeutic cancer vaccine containing tumor-associated neoantigens and immunostimulants in a deliver system Active 05-Feb-2016
US-20200376101-A1 Therapeutic cancer vaccine containing tumor-associated neoantigens and immunostimulants in a deliver system Active 05-Feb-2016
US-20170224796-A1 Therapeutic cancer vaccine containing tumor-associated neoantigens and immunostimulants in a delivery system Inactive 05-Feb-2016 A61K39/0011
To view Xeme Biopharma’s complete patent history, request access »

Xeme Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xeme Biopharma Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Keiretsu Forum Angel Group Minority
TheraTest VC-Backed Company Majority
U.S. Department of Health and Human Services Government
To view Xeme Biopharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Xeme Biopharma FAQs

  • When was Xeme Biopharma founded?

    Xeme Biopharma was founded in 2005.

  • Where is Xeme Biopharma headquartered?

    Xeme Biopharma is headquartered in Monmouth Junction, NJ.

  • What is the size of Xeme Biopharma?

    Xeme Biopharma has 4 total employees.

  • What industry is Xeme Biopharma in?

    Xeme Biopharma’s primary industry is Drug Discovery.

  • Is Xeme Biopharma a private or public company?

    Xeme Biopharma is a Private company.

  • What is the current valuation of Xeme Biopharma?

    The current valuation of Xeme Biopharma is .

  • What is Xeme Biopharma’s current revenue?

    The current revenue for Xeme Biopharma is .

  • How much funding has Xeme Biopharma raised over time?

    Xeme Biopharma has raised $400K.

  • Who are Xeme Biopharma’s investors?

    , Keiretsu Forum, TheraTest, and U.S. Department of Health and Human Services have invested in Xeme Biopharma.

  • When was Xeme Biopharma acquired?

    Xeme Biopharma was acquired on 01-Apr-2021.

  • Who acquired Xeme Biopharma?

    Xeme Biopharma was acquired by R2T Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process